TB-500 is an isolated fragment of TB4, consisting of only amino acids 17 to 23, whereas TB4 is the full peptide with 43 amino acids. There is limited data supporting the use of TB-500, and the claims made about it are often not substantiated by research.
This video differentiates between TB4 and TB-500, explaining that TB-500 is a fragment of TB4 and that much of the marketed information about TB-500 is not supported by research. The speaker delves into the clinical research behind TB4, discussing its potential benefits and risks, particularly in the context of ocular conditions and cancer concerns. The video aims to provide an evidence-based overview to help viewers discern between scientifically studied compounds and marketed claims.
The video focuses on the clinical research of TB4 for healing and recovery, noting its angiogenic and anti-apoptotic properties, and its potential role in muscular skeletal and tissue recovery. However, it also highlights that the research for TB4 is ongoing and that some aspects, like its systemic use, are understudied. The video does not explicitly state which peptide is "best" for healing, but rather provides a detailed examination of the research available for TB4.
